Showing results (1-10 of 14) with videos related to
Sort By:
Pageof 2
Gan to Kagaku Ryoho. Cancer & Chemotherapy|March 25, 2010
[Successful induction of complete cytogenetic response with low-dose imatinib mesylate in an accelerated phase chronic myelogenous leukemia patient who developed severe bone marrow aplasia following standard-dose imatinib mesylate therapy]Tomonori Nakazato, Kazuhito Suzuki, Ai Mihara, et al.International Journal of Hematology|June 1, 2004
Thalidomide-induced severe neutropenia during treatment of multiple myelomaYutaka Hattori, Tsunayuki Kakimoto, Shinichiro Okamoto, et al.Internal Medicine (Tokyo, Japan)|October 17, 2009
Refractory plasmablastic type myeloma with multiple extramedullary plasmacytomas and massive myelomatous effusion: remarkable response with a combination of thalidomide and dexamethasoneTomonori Nakazato, Kazuhito Suzuki, Ai Mihara, et al.[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|July 30, 2009
[CD4-positive diffuse large B-cell lymphoma]Tomonori Nakazato, Kazuhito Suzuki, Ai Mihara, et al.[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|April 10, 2010
[Intravascular large B-cell lymphoma with pontine involvement successfully treated with R-hyper-CVAD/R-MTX-Ara-C regimen]Tomonori Nakazato, Kazuhito Suzuki, Ai Mihara, et al.[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|December 3, 2008
[Sideroblastic anemia after prolonged linezolid therapy]Tsunayuki Kakimoto, Tomonori Nakazato, Reiko Miura, et al.[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|May 15, 2010
[Severe bortezomib-induced peripheral neuropathy in a patient with multiple myeloma]Yukinari Sanada, Tomonori Nakazato, Kazuhito Suzuki, et al.[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|January 31, 2006
[Persistent neutrophilia occurring after pneumonia: a differential diagnosis of neutrophilia based on the WHO classification]Takatsune Shimizu, Yoshitaka Miyakawa, Takayuki Mitsuhashi, et al.Cancer Science|April 4, 2008
Single-institute phase 2 study of thalidomide treatment for refractory or relapsed multiple myeloma: prognostic factors and unique toxicity profileYutaka Hattori, Shin-ichiro Okamoto, Naoki Shimada, et al.CEN Case Reports|May 1, 2020
A case of proliferative glomerulonephritis with immunoglobulin A1-lambda deposits successfully treated by chemotherapyYasuo Kusunoki, Tomoko Namba-Hamano, Tsunayuki Kakimoto, et al.Pageof 2